Patrik Sedlar and William Berntö of Svalner Atlas Advisors draw on case law to question whether the Swedish Tax Agency’s ...

Guo Guangchang, Chairman of Fosun International Limited (HKEX: 0656), issued a letter to its shareholders today, outlining the Company's strategic direction, accomplishments, and future plans.

Ultralife Corporation (NASDAQ:ULBI) reported operating results for the fourth quarter and full year ended December 31, 2025 as follows: Fourth Quarter: Sales of $48.5 million compared to $43.9 million ...

ALLY Robotic Cataract Laser Systems® (“ALLY Systems”) placed in 4Q 2025; Backlog of 13 ALLY Systems pending installation as of December 31, ...

Monika Bieri and Daniel Schönenberger of Tax Partner use a Swiss lens to examine how workforce mobility is reshaping transfer ...

Submitted GraftAssureDx™ for kidney transplant rejection testing for FDA review on Wednesday, March 25Welcomed second ...

Detailed price information for Nexa Resources S.A. (NEXA-N) from The Globe and Mail including charting and trades.

Peraso Inc. (NASDAQ:PRSO) Q4 2025 Earnings Call Transcript March 16, 2026 Operator: Good afternoon, and welcome to the Peraso Inc. Fourth Quarter 2025 Conference Call. At this time, all participants ...

Ares Capital is a great choice for income investors at this price. Click here to find out why ARCC stock is a Buy.

Multinationals often use transfer pricing to shift profits to low-tax jurisdictions, reducing their global tax burden.

Precigen transitioned to a commercial stage company with the US approval of PAPZIMEOS(TM) (zopapogene imadenovec-drba), the first-and-only FDA-approved treatment for adults with RRP, in August 2025 -- ...